<DOC>
	<DOCNO>NCT01653587</DOCNO>
	<brief_summary>Among non-ST-segment elevation acute coronary syndrome patient submit early invasive strategy randomize transfemoral transradial approach , AngioSeal vascular closure device would decrease prevalence vascular complication puncture site , reach non-inferiority criterion compare radial access .</brief_summary>
	<brief_title>AngioSeal Versus Radial Approach Acute Coronary Syndrome</brief_title>
	<detailed_description>Antithrombotic therapy percutaneous surgical myocardial revascularization procedure basis treatment patient admit non-ST-segment elevation acute coronary syndrome . However , desire reduction recurrence ischemic event complication increase incidence bleeding . Since arterial puncture follow insertion introducer become standard method perform invasive cardiovascular procedure , complication relate vascular access become important bleeding site . Among strategy decrease vascular complication , transradial approach well stablished alternative transfemoral approach . For part , vascular closure device introduce decrease vascular complication , homeostasis time ambulation time patient submit invasive procedure transfemoral access . Rapidly incorporated clinical practice , device date show conflict result regard safety efficacy . The inconsistency data prove safety limit routine adoption strategy prevent vascular complication , require evidence adequately design randomized study end .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>NonSTsegment elevation ACS patient [ ischemic symptom suspicious nonSTsegment elevation ACS ( unstable angina nonSTsegment elevation AMI ) define clinical presentation compatible new manifestation worsen chest pain characteristic ischemia , rest minimum effort , last 10 minute , least one follow item : ( ) ECG change compatible new ischemia ( ST segment depression least 1 mm , transient ST segment elevation , ST segment elevation ≤ 1 mm , T wave inversion &gt; 2 mm least 2 contiguous shunt ) ; ( b ) cardiac enzyme ( CKMB troponin T I ) upper normality range limit ; ( c ) patient &gt; 60 year age without ECG myocardial necrosis marker change , however previous documentation coronary atherosclerotic disease ( CAD ) , confirm previous hospitalization due AMI , previous percutaneous surgical myocardial revascularization procedure , significant CAD confirm coronary angiography , positive functional test myocardial ischemia ] ; Intention submit patient early invasive strategy consist coronary angiography immediately follow PCI , applicable , first 72 hour admission ; Signed informed consent ; Patient eligible transradial transfemoral coronary angiography PCI , prerequisites : ( ) palpable radial artery normal Allen test or/and oximetry test , ( b ) familiarity operator radial femoral technique use AngioSeal , ( c ) agreement operator use access route determine randomization process . Less 18 year age ; Pregnancy ; Chronic use vitamin K antagonists direct thrombin inhibitor , oral Xafactor antagonist ; Hypersensitivity antiplatelet and/or anticoagulant drug ; Active bleeding high bleeding risk ( severe liver failure , active peptic ulcer , creatinine clearance &lt; 30 mL/min , platelet count &lt; 100.000 mm3 ) ; Uncontrolled systemic hypertension ; Cardiogenic shock ; Previous myocardial revascularization surgery ≥ 1 internal mammary radial artery graft ; Documented chronic peripheral arterial disease prevent use femoral technique ; Severe concomitant disease life expectancy 12 month ; Participation drug device investigative clinical trial last 30 day ; Indication elective percutaneous coronary intervention perform moment different immediately coronary angiography ; Medical , geographic social condition impair participation study inability understand sign inform consent term .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Transradial Approach</keyword>
	<keyword>Transfemoral Approach</keyword>
	<keyword>Vascular Closure Device</keyword>
</DOC>